Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mitochondria Ribosome profiling (mitoRiboSeq) of RK1 Knock out cell line

ABSTRACT: Mitochondria Ribosome profiling (mitoRiboSeq) of RK1 Knock out cell line

PROVIDER: PRJEB52623 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Mitochondria Ribosome profiling (mitoRiboSeq) of RF1 Knock out cell line

Project description:Mitochondria Ribosome profiling (mitoRiboSeq) of RF1 Knock out cell line

| PRJEB57800 | ENA

Mitoribosome profiling (MitoRiboSeq) data from HEK WT and mtRF1 knockout cell lines

Project description:Mitochondrial translation was investigated by mitochondrial ribosome profiling (mitoRiboSeq) in three HEK293 cell lines: HEK293 wildtype, mtRF1 knockout 1, and mtRF1 knockout 2

2022-12-01 | E-MTAB-11687 | biostudies-arrayexpress

Mitoribosome profiling (MitoRiboSeq) data from HEK293T wild-type, TACO1 knockout, and TACO1 reconstituted cells

Project description:Mitochondrial translation was investigated by mitochondrial ribosome profiling (mitoRiboSeq) in three HEK293T cell lines: HEK293T wild-type (WT), TACO1 knockout (TACO1-KO), and TACO1 reconstituted (TACO1-KO + TACO1) cells

2025-01-29 | E-MTAB-14071 | biostudies-arrayexpress

Mitoribosome profiling (MitoRiboSeq) data from HEK293 wild-type, mtRF1a KO, mtRF1/mtRF1a dKO; and N2a wild-type, mtRF1 KO, mtRF1a KO, mtRF1/mtRF1a dKO cells

Project description:The function of the mitochondrial release factors mtRF1 and mtRF1a was investigated by mitochondrial ribosome profiling (mitoRiboSeq) in Flp-In T-Rex human embryonic kidney 293 (HEK293) and mouse neuroblastoma Neuro-2a (N2a) cell lines.

2026-03-01 | E-MTAB-15326 | biostudies-arrayexpress

Pseudomonas aeruginosa strain:RK1

Project description:Pseudomonas aeruginosa strain:RK1 Genome sequencing and assembly

| PRJNA813755 | ENA

Small RNA sequencing of wild-type and Mrpp3 knock out mouse heart mitochondria

Project description:Small RNA sequencing was used to examine RNA degradation products in mitochondria from mice lacking the nuclease subunit of the mitochondrial RNase P (MRPP3).

2017-03-23 | GSE94005 | GEO

Expanding the Coding Potential of the Mitochondrial Genome with MitoRiboSeq

Project description:The mitochondrial genome encodes 13 well-characterized mRNAs but, similar to the nuclear genome, it has the potential to encode many additional proteins through previously unannotated open reading frames. Using MitoRiboSeq, we detected dozens of new mitochondrial-derived microproteins in both cell lines and liver tissues. We demonstrate that MOTS-c, a previously described microprotein, shows a significant decrease during senescence induction, and its supplementation is sufficient to prevent key cellular dysfunctions associated with this process. This work significantly deepens our understanding of the mitochondrial genome and underscores its relevance for functional and therapeutic discoveries.

2026-01-01 | GSE285792 | GEO

Parapedobacter indicus strain:RK1 | isolate:DSM 28470

Project description:Parapedobacter indicus RK1 genome sequencing

| PRJNA335119 | ENA

Xylaria striata strain:RK1-1

Project description:Xylaria striata strain:RK1-1 Genome sequencing and assembly

| PRJNA304662 | ENA

Transcriptome analysis of memantine-treated Shank2 wild-type and knock-out mice

Project description:Shank2 is an excitatory postsynaptic scaffolding protein strongly implicated in autism spectrum disorders (ASD). Shank2-mutant mice with a homozygous deletion of exons 6 and 7 show decreased NMDA receptor (NMDAR) functions and autistic-like behaviors in juvenile (~postnatal day or P21) and adult (> P56) stages that are rescued by NMDAR activation. These mice, however, show an opposite change increased NMDAR functions—at ~P14, and NMDAR suppression by early and chronic memantine treatment during P7–21 prevents NMDAR hypofunction and autistic-like behaviors at juvenile (~P21) and adult (~P56) stages. To explore molecular mechanisms underlying the long-lasting effects of early memantine treatment, we performed RNA-Seq analysis of forebrains from wild-type and Shank2-mutant mice early and chronically treated with vehicle or memantine. Memantine-treated Shank2-mutant mice showed upregulations of chromatin-related genes and downregulations of mitochondria- and ribosome-related genes. In addition, vehicle-treated Shank2-mutant mice showed transcriptomic patterns that are largely opposite to those observed in ASD, as supported by the expression patterns of ASD-risk/related genes and cell-type-specific genes. These patterns, likely representing compensatory changes, were weakened by early memantine treatment. These results suggest that early chronic memantine treatment in Shank2-mutant mice alters chromatin- and mitochondria/ribosome-related gene expressions and weakens anti-ASD transcriptomic patterns.

2021-10-06 | GSE171931 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data